2-hydroxy-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one, 97%, 100mg

1-Boc-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole, 97.0%, 5g

4-Fluorotetrahydro-2H-pyran-4-carboxylic acid, 95.0%, 1g

1,2-Bis(diphenylphosphino)ethane, 95.00%, 1g

6-Bromo-4-methylpyridin-2-amine, 95.0%, 1g

1-Cyclopropyl-4-ethynyl-1H-pyrazole, 98%, 100mg

(R)-Morpholine-3-carboxylic acid, 95.0%, 250mg

2-(4,5-Dimethoxy-2-(thiomorpholin-4-ylsulfonyl)phenyl)acetic acid, 95%, 1g

Ethyl Indazole-5-carboxylate>98.0%(GC)1g

Celulosa microcristalina, para cromatografía en capa fina, 100 g, envase de plástico.

(Z)-2-(benzo[d]thiazol-2-yl)-3-(2-chloro-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)acrylonitrile, 97%, 500mg

2-chloro-2-(4-chlorophenyl)acetic acid, 95.0%, 500mg

2,2,3,3,3-Pentafluoro-1-propanol>98.0%(GC)25g